Difference between revisions of "Virag L"
From Bioblast
Beno Marija (talk | contribs) |
Nirschl Lisa (talk | contribs) ย |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
|COST= Member | |COST= Member | ||
|COST WG3 = WG3 | |COST WG3 = WG3 | ||
|COST Mentor= Mentor | |||
}} | }} | ||
ย | : [[Management_Committee_MitoEAGLE#MC_Members|MC Member]] - [[Management Committee MitoEAGLE]] | ||
{{Person | {{Person | ||
|lastname=Virag | |lastname=Virag | ||
Line 20: | Line 21: | ||
== | == MitoEAGLE == | ||
****: '''Benefits for COST and for the COST Action | ****: '''Benefits for COST and for the COST Action MitoEAGLE''' | ||
:::: As a PARylation guy I keep running into situations were this nuclear process impacts on mitochondrial function and the nature of this crosstalk is far from being simple. Moreover, the importance of gender issue can not be overstated. E.g. PARP inhibitors (or K.O.?) protect male mice but not females from stroke. We are aware of this gender differences but could not get to the roots of it. The work in this consortion might take us a bit further on this bumpy road. | :::: As a PARylation guy I keep running into situations were this nuclear process impacts on mitochondrial function and the nature of this crosstalk is far from being simple. Moreover, the importance of gender issue can not be overstated. E.g. PARP inhibitors (or K.O.?) protect male mice but not females from stroke. We are aware of this gender differences but could not get to the roots of it. The work in this consortion might take us a bit further on this bumpy road. |
Latest revision as of 17:21, 12 January 2018
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Virag L
MitoPedia topics: EAGLE
COST: Member
COST WG3: WG3
COST Mentor: Mentor
Name | Virag Laszlo, Prof. M.D., Ph.D. D.Sc. |
---|---|
Institution | Dept. Medical Chemistry
Medical and Health Science Center University of Debrecen |
Address | Elettudomanyi Epulet 3.311, 4032 |
City | Debrecen |
State/Province | |
Country | Hungary |
lvirag@med.unideb.hu | |
Weblink | |
O2k-Network Lab | HU Debrecen Virag L |
Labels:
Publications
Add references to your publications
Abstracts
Published | Reference | |
---|---|---|
Verebne Tar 2016 Abstract MitoFit Science Camp 2016 | 2016 | Investigating the role of the proteasome activator PA200 in mitochondrial homeostasis in a cellular model for Huntingtonโs disease. |
MitoEAGLE
- Benefits for COST and for the COST Action MitoEAGLE
- As a PARylation guy I keep running into situations were this nuclear process impacts on mitochondrial function and the nature of this crosstalk is far from being simple. Moreover, the importance of gender issue can not be overstated. E.g. PARP inhibitors (or K.O.?) protect male mice but not females from stroke. We are aware of this gender differences but could not get to the roots of it. The work in this consortion might take us a bit further on this bumpy road.